GOP senators take issue with FDA's use of draft guidances

05/9/2014 | (Boston)

Sens. Orrin Hatch, R-Utah, Richard Burr, R-N.C., Lamar Alexander, R-Tenn., and Johnny Isakson, R-Ga., are concerned with the FDA's use of draft guidelines governing drugs and medical devices. The draft guidelines, which are issued for comment purposes only, are "increasingly becoming default FDA policy" and "are not being revised, finalized, or withdrawn in a timely manner," the senators wrote in a letter to FDA Commissioner Dr. Margaret Hamburg.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI